1. Rack1 Mediates the Interaction of P-Glycoprotein with Anxa2 and Regulates Migration and Invasion of Multidrug-Resistant Breast Cancer Cells
   Yi Yang et al, 2016, IJMS CrossRef
2. Elevated STAT3 Signaling-Mediated Upregulation of MMP-2/9 Confers Enhanced Invasion Ability in Multidrug-Resistant Breast Cancer Cells
   Fei Zhang et al, 2015, IJMS CrossRef
3. Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
   Robert Cornelison et al, 2017, IJMS CrossRef
4. Targeting Metastasis with Snake Toxins: Molecular Mechanisms
   Félix Urra et al, 2017, Toxins CrossRef
5. Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells
   Xianqi Zhao et al, 2015, Viruses CrossRef
6. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells
   Anna Klimaszewska-Wiśniewska et al, 2018, IJMS CrossRef
7. Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
   Tzu-Hua Chang et al, 2011, Am J Respir Crit Care Med CrossRef
8. Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers
   Tze-Sian Chan et al, 2019, Front. Oncol. CrossRef
9. The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis
   null Bregenzer et al, 2019, Cancers CrossRef
10. Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial
    Fatéméh Dubois et al, 2019, Cancers CrossRef
11. Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library Screen
    Sugandha Bhatia et al, 2020, Cancers CrossRef
12. Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology
    Athina A. Kyriazi et al, 2020, IJMS CrossRef
13. Specific c-Jun N-Terminal Kinase Inhibitor, JNK-IN-8 Suppresses Mesenchymal Profile of PTX-Resistant MCF-7 Cells through Modulating PI3K/Akt, MAPK and Wnt Signaling Pathways
    Pelin Ozfiliz Kilbas et al, 2020, Biology CrossRef
14. SCRIB Is Involved in the Progression of Ovarian Carcinomas in Association with the Factors Linked to Epithelial-to-Mesenchymal Transition and Predicts Shorter Survival of Diagnosed Patients
    Usama Khamis Hussein et al, 2021, Biomolecules CrossRef
15. The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
    Hongmei Cui et al, 2021, Front. Pharmacol. CrossRef
16. The role of epithelial–mesenchymal transition-regulating transcription factors in anti-cancer drug resistance
    Jihye Seo et al, 2021, Arch. Pharm. Res. CrossRef
17. Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition.
    Jingjing Sha et al, 2021, Biomolecules CrossRef
18. Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells.
    Yali Fan et al, 2021, Front Cell Dev Biol CrossRef
19. Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
    Andrew Sulaiman et al, 2021, Biomedicines CrossRef
20. Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations
    Amy H. Lee et al, 2022, Cancers CrossRef
21. Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells
    Qing-Quan Li et al, 2009 CrossRef
22. Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1
    Emilie Bousquet et al, 2009 CrossRef
23. Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
    Zhiwei Wang et al, 2009 CrossRef
24. Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer
    Ishwar N. Kohale et al, 2022, Cancers CrossRef
25. RNA sequencing and bioinformatics analysis revealed PACSIN3 as a potential novel biomarker for platinum resistance in epithelial ovarian cancer
    Gwan Hee Han et al, 2022, The Journal of Gene Medicine CrossRef
26. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms
    Malihe Rezaee et al, 2023, Front. Pharmacol. CrossRef
27. Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
    Masahiro Uehara et al, 2024, Cancer Drug Resist CrossRef
28. Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites
    Antonio Hrvat et al, 2024, Front. Immunol. CrossRef
29. Ginsenoside Re Suppress the Proliferation and Migration of MCF-7 Human Breast Cancer Cells
    Jin-Nyoung Ho, 2024, JKFN CrossRef
30. ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC
    Kathrin Böpple et al, 2024, Cell Death Dis CrossRef
31. Drug resistance biomarkers in ovarian cancer: a bibliometric study from 2017 to 2022
    Sindy Cabarca et al, 2024, Front. Oncol. CrossRef